Previous 10 | Next 10 |
DUBLIN , Sept. 8, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched the store brand equivalent of over-the-counter ("OTC") Voltaren ® Arthritis Pain (diclofenac sodium topical gel, 1%) to its retail partners and the produc...
Patent challenge initiated by Bausch Health Companies NESS ZIONA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug product...
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...
Perrigo ( PRGO +2.9% ) will acquire three Eastern European OTC skincare and hair loss treatment brands including Emolium, Iwostin and Loxon, from Sanofi, for an undisclosed consideration. More news on: Perrigo Company plc, Merger & acquisition news, Healthcare stocks...
DUBLIN , Aug. 11, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that it will acquire three Eastern European OTC skincare and hair loss treatment brands (Emolium ® , Iw...
New Drug Application for Epsolay® Submitted; Twyneo® New Drug Application on track for 2H 2020 Top-line generic product revenue of $1.1 million in 2Q 2020 Launch of additional generic product expected in 2Q 2021 NESS ZIONA, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) --...
Perrigo Company plc (PRGO) Q2 2020 Earnings Conference Call August 05, 2020 09:00 AM ET Company Participants Brad Joseph - VP, Global IR and Corporate Communications Murray Kessler - President and Chief Executive Officer Ray Silcock - Chief Financial Officer Conference Call Pa...
Perrigo (NYSE: PRGO ) Q2 results : More news on: Perrigo Company plc Read more ...
The following slide deck was published by Perrigo Company plc in conjunction with their 2020 Q2 earnings Read more ...
Perrigo (NYSE: PRGO ) : Q2 Non-GAAP EPS of $1.03 beats by $0.16 ; GAAP EPS of $0.44 beats by $0.03 . More news on: Perrigo Company plc, Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024 PR Newswire DUBLIN , July 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its secon...
2024-07-19 06:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire DUBLIN , July 10, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it has compl...